Skip to content

Clinical trials

Phase 2 Carcinoma in Situ trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma in Situ Phase: Phase 2 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20131
20171
20201
20231
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed3
Not yet recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CG Oncology, Inc.1
First Affiliated Hospital of Wenzhou Medical University1
H. Lee Moffitt Cancer Center and Research Institute1
Lepu Biopharma Co., Ltd.1
Merck Sharp & Dohme LLC1
Michael A. O'Donnell1
Protara Therapeutics1
Spectrum Pharmaceuticals, Inc1
Telormedix SA1
University of Massachusetts, Boston1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma in Situ11
Non-Muscle Invasive Bladder Neoplasms7
Urinary Bladder Neoplasms7
Carcinoma, Transitional Cell2
Carcinoma, Non-Small-Cell Lung1
Leukoplakia, Oral1
Lichen Planus, Oral1
Mouth Neoplasms1
Pulmonary Disease, Chronic Obstructive1
Squamous Cell Carcinoma of Head and Neck1

Trials

Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.